Torque Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Torque Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11123
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Torque Therapeutics Inc (Torque) is an immuno-oncology company focused on developing first-in-class deep primed T Cell therapeutics to cure cancer. Its product pipeline includes Deep IL-15 used for for hematologic and solid tumors; Deep IL-12 targeting solid tumors; and small-molecule Deep TLR Primed T Cells against solid tumors. The company’s deep-Priming technology platform is used to activate T cells to target multiple tumor antigens and direct immune-stimulatory drugs directly to the surface of these multi-target T cells that stimulate and direct the immune response in the tumor microenvironment. Torque is headquartered in Cambridge, Massachusetts, the US.

Torque Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Torque Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Torque Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Torque Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Torque Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Torque Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Torque Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Torque Raises USD25 Million in Series A Venture Financing 10
Torque Therapeutics Raises Additional USD16 Million in Venture Financing 11
Torque Therapeutics Raises USD5 Million in Venture Financing 12
Torque Therapeutics Inc – Key Competitors 13
Torque Therapeutics Inc – Key Employees 14
Torque Therapeutics Inc – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
Nov 02, 2018: Torque announces appointment of Immunotherapy pioneer F. Stephen Hodi, MD, to Scientific Advisory Board and Alex Bruni as COO/ CFO 16
Jul 25, 2018: Torque Appoints James Mullen as Chairman of Board of Directors, Maykin Ho, as Strategic Advisor to the Board of Directors, and Mario Sznol to Scientific Advisory Board 17
Clinical Trials 19
Apr 17, 2018: Torque Presents Preclinical Data at AACR Demonstrating that Deep-Primed IL-15 is Superior to Systemically Administered IL-15 for Increasing T Cell Infiltration and Tumor Killing Without Systemic Toxicity 19
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Torque Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Torque Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Torque Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Torque Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Torque Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Torque Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Torque Raises USD25 Million in Series A Venture Financing 10
Torque Therapeutics Raises Additional USD16 Million in Venture Financing 11
Torque Therapeutics Raises USD5 Million in Venture Financing 12
Torque Therapeutics Inc, Key Competitors 13
Torque Therapeutics Inc, Key Employees 14

List of Figures
Torque Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Torque Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Torque Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Torque Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Torque Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Torque Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Torque Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Torque Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Torque Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alibaba Group Holding Limited:企業の戦略・SWOT・財務情報
    Alibaba Group Holding Limited - Strategy, SWOT and Corporate Finance Report Summary Alibaba Group Holding Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • ITT Inc (ITT):企業の財務・戦略的SWOT分析
    ITT Inc (ITT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Aura Energy Ltd (AEE):企業の財務・戦略的SWOT分析
    Summary Aura Energy Ltd (Aura Energy) is a mining and mineral exploration and development company. The company’s business activities include acquisition, exploration, and development of uranium properties in Europe and Africa. Its projects comprise Haggan Uranium Project, Kallsedet Uranium Project, …
  • Michigan Public Power Agency:企業の発電所・SWOT分析2018
    Michigan Public Power Agency - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Marquee Energy Ltd (MQX):石油・ガス:M&Aディール及び事業提携情報
    Summary Marquee Energy Ltd (Marquee), formerly known as Alberta Oilsands Inc, is an upstream energy company that explores and produces oil, natural gas, and natural gas liquids from its assets in Michichi, Alberta. The company’s Michichi assets are in Michichi, Drumheller, Watts, Wildunn Creek, Deli …
  • Belk Inc:企業の戦略・SWOT・財務情報
    Belk Inc - Strategy, SWOT and Corporate Finance Report Summary Belk Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Oilinvest (Netherlands) BV:企業の戦略的SWOT分析
    Oilinvest (Netherlands) BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Ocado Group Plc:企業の戦略・SWOT・財務情報
    Ocado Group Plc - Strategy, SWOT and Corporate Finance Report Summary Ocado Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • GFI Informatique:企業の戦略・SWOT・財務分析
    GFI Informatique - Strategy, SWOT and Corporate Finance Report Summary GFI Informatique - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Nanion Technologies GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Nanion Technologies GmbH (Nanion) is a biotechnology company that develops new innovations in the field of ion channel research and screening. The company offers products such as port-a-patch, patchliner, syncropatch 96, syncropatch 384pe, npc-chips, vesicle prep pro, ordering information, s …
  • Velesto Energy Bhd (UMWOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Velesto Energy Bhd (Velesto) formerly UMW Oil & Gas Corp Bhd, a subsidiary of UMW Holdings Bhd, is an oil and gas company that offers drilling and oilfield services. The company’s services include offshore drilling, hydraulic workover services, threading, inspection and repair services. Its …
  • EMCORE Corporation (EMKR)-エネルギー分野:企業M&A・提携分析
    Summary EMCORE Corporation (EMCORE) is a communication network infrastructure equipment company that provides optical components and end-to-end solutions. It designs and manufactures indium phosphide optical chips, components, subsystems, and systems. The company produces its products through linear …
  • FMC Corp (FMC):企業の財務・戦略的SWOT分析
    FMC Corp (FMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Duke Energy Corp:企業の発電所・SWOT分析2018
    Duke Energy Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Black Rock Mining Ltd (BKT):企業の財務・戦略的SWOT分析
    Summary Black Rock Mining Ltd (BRML), formerly Green Rock Energy Ltd, is a mining and mineral exploration company. The company carries out the business of acquisition, exploration, and development of graphite properties. It also holds interest in Mahenge Graphite Project which includes high-grade fl …
  • Banco di Desio e della Brianza SpA:企業の戦略・SWOT・財務分析
    Banco di Desio e della Brianza SpA - Strategy, SWOT and Corporate Finance Report Summary Banco di Desio e della Brianza SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Gebr. Heinemann SE & Co. KG:戦略・SWOT・企業財務分析
    Gebr. Heinemann SE & Co. KG - Strategy, SWOT and Corporate Finance Report Summary Gebr. Heinemann SE & Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Lindsay Corporation:企業の戦略・SWOT・財務情報
    Lindsay Corporation - Strategy, SWOT and Corporate Finance Report Summary Lindsay Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Windtree Therapeutics Inc (WINT):医療機器:M&Aディール及び事業提携情報
    Summary Windtree Therapeutics Inc (Windtree Therapeutics), formerly Discovery Laboratories, Inc. is a specialty biotechnology company. It focuses on the development of novel KL4 surfactant therapies for patients with respiratory diseases and other potential applications. The company’s lead developme …
  • CBR Systems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CBR Systems Inc (CBR), a subsidiary of AMAG Pharmaceuticals Inc, is a stem cell company that offers new born stem cells. The company provides collection, processing, and long-term cryopreservation services for newborn umbilical cord blood stem cells and cord tissue units. It offers cord bloo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆